Tissue	Disease	Species	symbol	ID	Platform	Type	Expression	Target	Pathway	Method	Drug	Function	PMID	Title	Year	
heart	atrial_fibrillation	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	MIR-133A-3P	NA	qPCR	no	"Atrial fibrillation(AF)-induced myocardial fibrosis, and the functional regulatory pathway of Miat targeting miR-133a-3p."	32130618	LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis	https://pubmed.ncbi.nlm.nih.gov/32130618/	2020
heart	myocardial_infarction	mus_musculus	Mirt1	ENSMUSG00000097636	Ensembl	lncrna	down-regulation	NA	NF-KAPPA B SIGNALING PATHWAY	NA	no	Down-regulation of miRt1 improves myocardial i/r injury in aged diabetic rats by inhibition of activation of NF-KB signaling pathway.	30611788	Down-regulation of myocardial infarction associated transcript 1 improves myocardial ischemia-reperfusion injury in aged diabetic rats by inhibition of activation of NF-KB signaling pathway	https://pubmed.ncbi.nlm.nih.gov/30611788/	2019
heart	endomyocardial_fibrosis	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	down-regulation	PTEN-MMP2	PI3K-AKT SIGNALING PATHWAY	 PCR; immunofluorescence etc.	no	Gas5 plays a suppressive role in cardiac fibrosis via negative regulation of miR-21. Gas5 that upregulated or downregulated the expression of PTEN through miR-21 in cardiac fibroblasts.	28526319	LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway	https://pubmed.ncbi.nlm.nih.gov/28526319/	2017
heart	endomyocardial_fibrosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	DUSP5	MAPK SIGNALING PATHWAY	 PCR; Masson's  trichrome staining etc.	no	"H19 endogenous expression is overexpressed in cardiac fibroblast and fibrosis tissues, and an opposite pattern is observed for Dusp5. H19 ectopic overexpression reduces Dusp5 abundance and increases the proliferation of cardiac fibroblast, whereas h19 silencing causes the opposite effects."	27318893	Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis	https://pubmed.ncbi.nlm.nih.gov/21412773/	2016
heart	endomyocardial_fibrosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	CTGF	NA	 PCR; dual-luciferase reporter assay etc.	no	"H19 knockdown could enhance the antifibrotic role of miR-455 and attenuate the CTGF expression and further decrease fibrosis-associated protein synthesis (collagen i, iii, and alfa-SMA)."	28753062	Long Noncoding RNA H19 Acts as a Competing Endogenous RNA to Mediate CTGF Expression by Sponging miR-455 in Cardiac Fibrosis	https://pubmed.ncbi.nlm.nih.gov/28753062/	2017
heart	heart_failure	mus_musculus	Kcnq1ot1	ENSMUSG00000101609	Ensembl	lncrna	down-regulation	FUS	NA	qRT-PCR; 	no	"Kcnq1ot1 ovexpression improved myocardial histopathological changes, reduced myocardial fibrosis areas, down-regulated FUS expression, and inhibited cell apoptosis of heart failure(HF) mice."	32497620	LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure	https://pubmed.ncbi.nlm.nih.gov/32497620/	2020
heart	diabetic_cardiomyopathy	mus_musculus	Kcnq1ot1	ENSMUSG00000101609	Ensembl	lncrna	up-regulation	NA	NOD-LIKE RECEPTOR SIGNALING PATHWAY	dual-luciferase reporter assay	no	Kcnq1ot1/miR-214-3p/caspase-1/TGF-beta signal pathway presents a new mechanism of diabetes cardiomyopathy (DCM) progression and could potentially be a novel therapeutic target.	30250027	Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy	https://pubmed.ncbi.nlm.nih.gov/30250027/	2018
heart	endomyocardial_fibrosis	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	MIR-24;FURIN	TGF-BETA SIGNALING PATHWAY	 PCR; dual-luciferase reporter assay etc.	no	Knockdown of endogenous miat by its sirna reduced cardiac fibrosis and improved cardiac function and restored the deregulated expression of the fibrosis-related regulators.	28198439	MIAT Is a Pro-fibrotic Long Noncoding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium	https://pubmed.ncbi.nlm.nih.gov/28198439/	2016
heart	cardiovascular_diseases	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	up-regulation	MIRI	PI3K-AKT SIGNALING PATHWAY	dual-luciferase reporter assay	no	Lncrna gas5 was able to regulate miRNA through the PI3k/Akt apoptosis pathway by sponging miR-532-5p.	31985016	Long non-coding RNA GAS5 regulates myocardial ischemia-reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR-532-5p	https://pubmed.ncbi.nlm.nih.gov/31985016/	2020
heart	myocardial_infarction	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	MIR-145	TGF-BETA SIGNALING PATHWAY	 qRT-PCR; Masson's  trichrome staining	no	Lncrna malat1 promotes cardiac fibrosis and deteriorates cardiac function post-myocardial infarction (MI) by regulating TGF-beta activity via miR-145.	30146700	Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model	https://pubmed.ncbi.nlm.nih.gov/30146700/	2019
heart	endomyocardial_fibrosis	mus_musculus	Snhg7	ENSMUSG00000086775	Ensembl	lncrna	up-regulation	MIR-34-5P	NA	qRT-PCR;  dual-luciferase reporter assay etc.	no	Lncrna snhg7 could promote cardiac fibrosis via targeting miR-34-5p through acting as a ceRNA in mice aftermyocardial infarction (MI).	32507765	LncRNA SNHG7 promotes cardiac remodeling by upregulating ROCK1 via sponging miR-34-5p	https://pubmed.ncbi.nlm.nih.gov/32507765/	2020
heart	heart_failure	mus_musculus	Fendrr	ENSMUSG00000097336	Ensembl	lncrna	up-regulation	TAC	NA	qRT-PCR	yes	"Loss-function of fendrr significantly alleviated the cardiac fibrosis phenotypes induced by TAC, indicating that fendrr is required for the pathogenesis of cardiac fibrosis."	31982134	Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis	https://pubmed.ncbi.nlm.nih.gov/31982134/	2020
heart	endomyocardial_fibrosis	mus_musculus	Rmrp	ENSMUSG00000115420	Ensembl	lncrna	up-regulation	NA	NA	dual-luciferase reporter assay	no	miR-613 was indicated to mediate the promoting effect of RMRP on cardiac fibroblast activation.	31485650	Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR-613	https://pubmed.ncbi.nlm.nih.gov/31485650/	2019
heart	diabetic_cardiomyopathy	mus_musculus	Crnde	ENSMUSG00000031736	Ensembl	lncrna	down-regulation	NA	TGF-BETA SIGNALING PATHWAY	NA	no	Overexpression of Crnde attenuated cardiac fibrosis and enhanced cardiac function in mice with diabetes cardiomyopathy (DCM).	30748104	Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy	https://pubmed.ncbi.nlm.nih.gov/30748104/	2019
heart	endomyocardial_fibrosis	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	down-regulation	NA	PI3K-AKT SIGNALING PATHWAY	RT-PCR; 	no	"Overexpression of gas5 after injection with PCDNA-gas5 could attenuate cardiac fibrosis and improve cardiac function through increasing the expression of PTEN and decreasing the expression of MMP-2, alfa-SMA, and collagen i."	31173316	Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice	https://pubmed.ncbi.nlm.nih.gov/31173316/	2019
heart	endomyocardial_fibrosis	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	up-regulation	HMGB1	NF-KAPPA B SIGNALING PATHWAY	qRT-PCR;  cell counting kit-8 analysis etc.	yes	Palmitic acid (PA) can induce gas5 expression and that the downregulation of gas5 alleviated pa-induced myocardial inflammatory injury through the miR-26a/HMGB1/NF-KB axis.	30365114	Downregulation of growth arrest-specific transcript 5 alleviates palmitic acid-induced myocardial inflammatory injury through the miR-26a/HMGB1/NF-KB axis	https://pubmed.ncbi.nlm.nih.gov/30365114/	2018
heart	endomyocardial_fibrosis	mus_musculus	Rassf1	ENSMUSG00000010067	Ensembl	lncrna	up-regulation	NA	NA	dual-luciferase reporter assay	no	Rassf1-as1 inhibits the translation of rassf1a to exacerbate cardiac fibrosis in mice.	30571844	"RASSF1-AS1, an antisense lncRNA of RASSF1A, inhibits the translation of RASSF1A to exacerbate cardiac fibrosis in mice"	https://pubmed.ncbi.nlm.nih.gov/30571844/	2019
heart	endomyocardial_fibrosis	mus_musculus	Sail	NA	NA	lncrna	down-regulation	NA	TGF-BETA SIGNALING PATHWAY	NA	no	"SAIL inhibited the fibrotic process by directly binding with SAFB via 23 conserved nucleotide sequences, in turn blocked the access of SAFB to RNA pol II (RNA polymerase II) and reduced the transcription of fibrosis-related genes. Intriguingly,the human conserved fragment of SAIL (hSAIL) significantly suppressed the proliferation and collagen production of human cardiac fibroblasts."	33675440	SAIL: a new conserved anti-fibrotic lncRNA in the heart	https://pubmed.ncbi.nlm.nih.gov/33675440/	2021
heart	heart_failure	mus_musculus	Sox2ot	ENSMUSG00000105265	Ensembl	lncrna	up-regulation	NA	TGF-BETA SIGNALING PATHWAY	qRT-PCR;  dual-luciferase reporter assay etc.	no	Sox2ot/smad3 feedback loop promotes cardiac fibrosis in heart failure(HF).	32959533	LncRNA SOX2OT/Smad3 feedback loop promotes myocardial fibrosis in heart failure	https://pubmed.ncbi.nlm.nih.gov/32959533/	2020
heart	endomyocardial_fibrosis	mus_musculus	AK081284	NA	NA	lncrna	up-regulation	NA	NA	RT-PCR	no	"The levels of long noncoding RNA-AK081284 were increased in the cardiac fibroblasts (CFs) treated with high glucose or interleukin-17(IL-17). Knockout of IL-17 abrogated high glucose induced upregulation of AK081284. Overexpression of AK081284 in cultured CFs promoted the production of collagen and TGF-beta1. Both high glucose and IL-17 induced collagen and TGF-beta1 production were mitigated by the application of the siRNA for AK081284. In summary, deletion of IL-17 is able to mitigate myocardial fibrosis and improve cardiac function of diabetic mice. The IL-17/AK081284/TGFbeta1 signaling pathway mediates high glucose induced collagen production."	29305939	Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice	https://pubmed.ncbi.nlm.nih.gov/29305939/	2018
heart	myocardial_infarction	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	down-regulation	KDM3A	NA	dual-luciferase reporter assays;qRT-PCR;  etc.	no	NA	31755219	LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A	https://pubmed.ncbi.nlm.nih.gov/31755219/	2020
heart	endomyocardial_fibrosis	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	MIR-29	NA	dual-luciferase reporter assay	no	NA	32795172	Mechanism underlying increased cardiac extracellular matrix deposition in perinatal nicotine-exposed offspring	https://pubmed.ncbi.nlm.nih.gov/32795172/	2020
heart	ventricular_dysfunction	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	MIR-29	NA	dual-luciferase reporter assay	no	NA	32795172	Mechanism underlying increased cardiac extracellular matrix deposition in perinatal nicotine-exposed offspring	https://pubmed.ncbi.nlm.nih.gov/32795172/	2020
intestine	colorectal_neoplasms	mus_musculus	Trp53cor1	100504267	Gene	lncrna	dysregulation	NA	NA	qRT-PCR etc.	NA	"One of them, lincRNA-p21, was regulated by p53 and contributed to apoptosis in mouse embryonic fibroblasts."	24012455	Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer	https://pubmed.ncbi.nlm.nih.gov/24012455/	2013
kidney	diabetic_nephropathy	mus_musculus	Cyp4b1-ps1	ENSMUSG00000081006	Ensembl	lncrna	down-regulation	NA	NA	Microarray	no	A novel long non-coding RNA CYP4B1 PS1-001 regulates proliferation and fibrosis in diabetic nephropathy.	26923441	A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/26923441/	2016
kidney	kidney_failure_chronic	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR; 	no	Activation of lncrna-gas5 attenuates kidney fibrosis by modulating miR-21 activity.	32791063	Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity	https://pubmed.ncbi.nlm.nih.gov/32791063/	2020
kidney	diabetic_nephropathy	mus_musculus	Neat1	ENSMUSG00000092274	Ensembl	lncrna	up-regulation	NA	PI3K-AKT SIGNALING PATHWAY	cell counting kit-8 analysis; MTT ASSAY	no	Decrease of neat1 repressed the proliferation and fibrosis in diabetic nephropathies via activating the Akt/mTOR signaling pathway.	30515796	Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway	https://pubmed.ncbi.nlm.nih.gov/30515796/	2019
kidney	acute_kidney_injury	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	NA	NA	small-RNA sequencing; whole genome expression analysis	no	Hypoxia-induced long non-coding RNA malat1 (metastasis associated lung adenocarcinoma transcript 1) to be upregulated in renal i/r injury.	29467431	Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury	https://pubmed.ncbi.nlm.nih.gov/29467431/	2018
kidney	nephritis_interstitia	mus_musculus	Arid2	ENSMUSG00000033237	Ensembl	lncrna	up-regulation	NA	TGF-BETA SIGNALING PATHWAY	qPCR; 	no	"In vitro knockdown of Arid2-IR from tubular epithelial cells produced no effect on TGF-beta-induced Smad3 signaling and fibrosis but inhibited interleukin-1beta-stimulated NF-KB-dependent inflammatory response. In contrast, overexpression of Arid2-IR promoted interleukin-1beta-induced NF-KB signaling and inflammatory cytokine expression without alteration of TGF-beta-induced fibrotic response. Furthermore, treatment of obstructed kidney with Arid2-IR shRNA blunted NF-KB-driven renal inflammation without effect on TGF-beta/Smad3-mediated renal fibrosis."	25743111	Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation	https://pubmed.ncbi.nlm.nih.gov/25743111/	2015
kidney	diabetic_nephropathy	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	down-regulation	FN1	NA	NA	no	"Knockdown of lncrna gas5 leads to antifibrosis by competitively binding miR-96-5p, which inhibits the expression of FN1."	31810140	LncRNA GAS5 exacerbates renal tubular epithelial fibrosis by acting as a competing endogenous RNA of miR-96-5p	https://pubmed.ncbi.nlm.nih.gov/31810140/	2020
kidney	diabetic_nephropathy	mus_musculus	Gm4419	ENSMUSG00000097055	Ensembl	lncrna	up-regulation	P50	NF-KAPPA B SIGNALING PATHWAY	qRT-PCR	no	"Lincrna-gm4419 may participate in the inflammation, fibrosis and proliferation in mesangial cells under high-glucose condition through NF-KB/Nlrp3 inflammasome signaling pathway."	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	Hottip	ENSMUSG00000055408	Ensembl	lncrna	up-regulation	NA	WNT SIGNALING PATHWAY	qRT-PCR;  MTT assay etc.	no	"Lncrna hottip/miR-455-3p/wnt2b axis plays an important role in cell proliferation, inflammation, and extracellular matrix (ecm) accumulation in diabetic nephropathy."	31934070	Long non-coding RNA Hottip modulates high-glucose-induced inflammation and ECM accumulation through miR-455-3p/WNT2B in mus musculus mesangial cells	https://pubmed.ncbi.nlm.nih.gov/31934070/	2019
kidney	diabetic_nephropathy	mus_musculus	Tug1	ENSMUSG00000056579	Ensembl	lncrna	down-regulation	TIMP3	NA	dual-luciferase reporter assay	no	Lncrna tug1 inhibited high glucose-stimulated NRK-52e cell fibrosis and renal fibrosis in diabetic nephropathies mice.	31933879	LncRNA TUG1 ameliorates diabetic nephropathy by inhibiting miR-21 to promote TIMP3-expression	https://pubmed.ncbi.nlm.nih.gov/31933879/	2019
kidney	kidney_failure_chronic	mus_musculus	Zfas1	ENSMUSG00000074578	Ensembl	lncrna	up-regulation	NA	WNT SIGNALING PATHWAY	dual-luciferase reporter assay	no	LncRNA ZFAS1 from HCM could promote cardiac fibrosis through WNT/beta-catenin signal via exosome pathways.	33640882	Exosome-derived long non-coding RNA ZFAS1 controls cardiac fibrosis in chronic kidney disease	https://pubmed.ncbi.nlm.nih.gov/33640882/	2021
kidney	diabetic_nephropathy	mus_musculus	Tmcc3	ENSMUSG00000020023	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR; 	no	Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.	27083175	Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/27083175/	2016
kidney	diabetic_nephropathy	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	ZEB2	NA	qRT-PCR;  dual-luciferase reporter assay	no	"Malat1 functions as a sponge RNA for miR-145 to derepress the expression of target gene zeb3, thereby inducing epithelial-mesenchymal transition (EMT) and fibrosis."	31081103	LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis	https://pubmed.ncbi.nlm.nih.gov/31081103/	2019
kidney	diabetic_nephropathy	mus_musculus	Oip5os1	ENSMUSG00000085438	Ensembl	lncrna	down-regulation	NA	HIF-1 SIGNALING PATHWAY	dual-luciferase reporter assay	no	Overexpression of 1700020i14rik inhibited cell proliferation and expressions of renal fibrosis markers through miR-34a-5p/sirt1/hif-1 alfa pathway in mouse mesangial cells under high glucose condition.	29700282	LincRNA 1700020I14Rik alleviates cell proliferation and fibrosis in diabetic nephropathy via miR-34a-5p/Sirt1/HIF-1alpha signaling	https://pubmed.ncbi.nlm.nih.gov/29700282/	2018
kidney	diabetic_nephropathy	mus_musculus	Xist	ENSMUSG00000086503	Ensembl	lncrna	up-regulation	CDKN1A	NA	dual-luciferase reporter assay	no	Silenced xist inducing miR-93-5p-dependent cdkn1a inhibition was beneficial for preventing renal interstitial fibrosis in diabetic nephropathies.	31545928	Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A	https://pubmed.ncbi.nlm.nih.gov/31545928/	2019
kidney	nephritis_interstitia	mus_musculus	Hotair	ENSMUSG00000086903	Ensembl	lncrna	up-regulation	NOTCH1	NA	qRT-PCR; 	no	"Silencing lncrna hotair can up-regulate miR-124 to block notch2 pathway, and thereby alleviating epithelial-mesenchymal transition and renal interstitial fibrosis."	29717517	LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124	https://pubmed.ncbi.nlm.nih.gov/29717517/	2019
kidney	diabetic_nephropathy	mus_musculus	Neat1	ENSMUSG00000092274	Ensembl	lncrna	up-regulation	NA	MAPK SIGNALING PATHWAY	NA	no	Silencing neat1 can reverse the activation of epithelial-mesenchymal transition and fibrosis caused by klotho silencing in a manner dependent on the erk1/3 signaling pathway.	32054986	Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway	https://pubmed.ncbi.nlm.nih.gov/32054986/	2020
kidney	nephritis_interstitia	mus_musculus	Hotair	ENSMUSG00000086903	Ensembl	lncrna	up-regulation	NOTCH1	NOTCH SIGNALING PATHWAY	NA	yes	"The contributory effect of lncrna hotair on renal interstitial fibrosis by activating the notch1/jagged1 signaling pathway via inhibition of miR-124, whereas administration of PAE can alleviate the effects of hotair on renal interstitial fibrosis."	30714138	Paeonol reverses promoting effect of the HOTAIR/miR-124/Notch1 axis on renal interstitial fibrosis in a rat model	https://pubmed.ncbi.nlm.nih.gov/30714138/	2019
kidney	nephritis_interstitia	mus_musculus	Tug1	ENSMUSG00000056579	Ensembl	lncrna	up-regulation	NA	TGF-BETA SIGNALING PATHWAY	 immunofluorescence etc.	no	Tug1 promotes epithelial-mesenchymal transition in TGF-beta-induced human renal proximal tubular epithelial cells via upregulation of beta-catenin levels by sponging miR-141-3p.	33135476	Silencing of the lncRNA TUG1 attenuates the epithelial-mesenchymal transition of renal tubular epithelial cells by sponging miR-141-3p via regulating beta-catenin	https://pubmed.ncbi.nlm.nih.gov/33135476/	2020
kidney	diabetic_nephropathy	mus_musculus	Snhg18	ENSMUSG00000096956	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	1500026H17Rik	ENSMUSG00000097383	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	2610035D17Rik	ENSMUSG00000087259	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	4930556M19Rik	ENSMUSG00000096971	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	6030443J06Rik	ENSMUSG00000097207	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	C330002G04Rik	ENSMUSG00000097930	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	D630029K05Rik	ENSMUSG00000031294	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	Snhg6	ENSMUSG00000098234	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	1700020I14Rik	ENSMUSG00000085438	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	AV099323	ENSMUSG00000087377	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	diabetic_nephropathy	mus_musculus	C920006O11Rik	ENSMUSG00000097574	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR	no	Twelve lncRNAs displayed the same expressional tendencies in both renal tissues and mesangial cells.	28151474	LincRNA-Gm4419 knockdown ameliorates NF-KB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy	https://pubmed.ncbi.nlm.nih.gov/28151474/	2017
kidney	renal_fibrosis	mus_musculus	3110045C21Rik	ENSMUSG00000097503	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 10D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	3110099E03Rik	ENSMUSG00000085582	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 11D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	3300005D01Rik	ENSMUSG00000096965	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 12D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	4833418N02Rik	ENSMUSG00000085287	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 13D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	9130409J20Rik	ENSMUSG00000085683	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 14D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	9330175E14Rik	ENSMUSG00000097194	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 15D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	A730020E08Rik	ENSMUSG00000097924	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 16D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	AI504432	ENSMUSG00000056145	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 17D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	AI662270	ENSMUSG00000087107	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 18D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	D630024D03Rik	ENSMUSG00000085772	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 19D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	D630029K05Rik	ENSMUSG00000031294	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 20D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gdap10	100504486	Gene	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 21D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm10069	ENSMUSG00000059659	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 22D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm10804	ENSMUSG00000075025	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 23D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm11752	ENSMUSG00000087404	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 24D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm12678	ENSMUSG00000084854	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 25D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm13412	ENSMUSG00000085017	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 26D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm16685	ENSMUSG00000097804	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 27D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Gm9951	ENSMUSG00000054618	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 28D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 29D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Neat1	ENSMUSG00000092274	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 30D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Snhg6	ENSMUSG00000098234	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 34D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	1810034E14Rik	ENSMUSG00000097101	Ensembl	lncrna	down-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 8D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	renal_fibrosis	mus_musculus	Epb41l4aos	ENSMUSG00000087590	Ensembl	lncrna	up-regulation	NA	NA	qPCR	no	"We identified a long list of differentially expressed lncRNA genes in a statistical significant manner (P<0.05).In particular, we identified 62 lncRNAs that were differentially expressed in SO vs 2D, 110 lncRNAs in SO vs 8D and 24 in 2D vs 9D ."	27189340	Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases	https://pubmed.ncbi.nlm.nih.gov/27189340/	2016
kidney	kidney_diseases	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR; pathway analysis; immunohistochemistry	no	NA	30914951	Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis	https://pubmed.ncbi.nlm.nih.gov/30914951/	2019
kidney	kidney_diseases	mus_musculus	Meg8	ENSMUSG00000097451	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR; pathway analysis; immunohistochemistry	no	NA	30914951	Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis	https://pubmed.ncbi.nlm.nih.gov/30914951/	2019
kidney	kidney_diseases	mus_musculus	Neat1	ENSMUSG00000092274	Ensembl	lncrna	up-regulation	NA	NA	NA	no	NA	32475133	Long noncoding RNA NEAT1 sponges miR-130 to modulate renal fibrosis by regulation of collagen type I	https://pubmed.ncbi.nlm.nih.gov/32475134/	2020
liver	liver_cirrhosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	dysregulation	LNCRNA H19	NA	flow cytometry etc.	no	Cholangiocyte-derived exosomal h19 plays a critical role in the progression of cholestatic liver fibrosis by promoting hsc differentiation and activation and represents a potential diagnostic biomarker and therapeutic target for cholangiopathies.	30985008	Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis	https://pubmed.ncbi.nlm.nih.gov/30985008/	2019
liver	liver_cirrhosis	mus_musculus	LFAR1	NA	NA	lncrna	down-regulation	LNC-LFAR1	TGF-BETA SIGNALING PATHWAY; NOTCH SIGNALING PATHWAY	qRT-PCR;  etc.	no	"Demonstrate that a liver-enriched lncrna, lnc-lfar1, promotes liver fibrosis and hsc activation by activating tgfbeta and notch signaling."	28747678	The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways	https://pubmed.ncbi.nlm.nih.gov/28747678/	2017
liver	carcinoma_hepatocellular	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	dysregulation	NA	NA	NA	NA	"HCC and HPBL have clearly different patterns of gene expression, with genes IGF2, Fibronectin, DLK1, TGFb1, MALAT1 and MIG6 being over-expressed in HPBL versus HCC"	17006932	Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas	https://pubmed.ncbi.nlm.nih.gov/17006932/	2006
liver	liver_cirrhosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	NA	TGF-BETA SIGNALING PATHWAY	 qRT-PCR; immunohistochemistry etc.	no	Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.	27350269	MeCP2 silencing of LncRNA H19 controls hepatic stellate cell proliferation by targeting IGF1R	https://pubmed.ncbi.nlm.nih.gov/27350269/	2016
liver	liver_cirrhosis	mus_musculus	LNCRNA-ATB	114004396	Gene	lncrna	up-regulation	LNCRNA-ATB	NA	qRT-PCR;  immunocytocH&E stainingmistry etc.	no	Lncrna-atb;Mir-200a;beta-Catenin regulatory axis likely contributed to the development of liver fibrosis in hcv patients. Knockdown of lncrna-atb might be a novel therapeutic target for hcv-related liver fibrosis.	28302418	LncRNA-ATB/microRNA-200a/beta-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis	https://pubmed.ncbi.nlm.nih.gov/28302418/	2017
liver	liver_cirrhosis	mus_musculus	Neat1	ENSMUSG00000092274	Ensembl	lncrna	dysregulation	NA	NA	NA	yes	Neat1 was significantly increased in ccl4-induced mice and activated hscs. Loss of neat1 suppressed liver fibrosis in vivo and in vitro. Klf6 and mir-122 were required for the effects of neat1 on hsc activation. Neat1 contributes to hsc activation via competitively binding mir-122. We disclose a novel neat1-mir-122-klf6 signaling cascade.	28864835	NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6	https://pubmed.ncbi.nlm.nih.gov/28864835/	2017
liver	liver_cirrhosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	dysregulation	LNCRNA-H19	AMPKA	RT-PCR;  immunofluorescence etc.	no	"Our results highlighted the role of lncrna-h19 in the metabolism of lipid droplets in hscs, and revealed a new molecular target for alleviating liver fibrosis."	32445757	HIF-1alfa-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKalfa pathway in hepatic stellate cells	https://pubmed.ncbi.nlm.nih.gov/32445757/	2020
liver	liver_cirrhosis	mus_musculus	Scarna10	ENSMUSG00000089617	Ensembl	lncrna	up-regulation	SCARNA10	NA	miRNA microarray chip detection etc.	no	"Our study identified a crucial role of scarna10 in liver fibrosis, providing a proof of this molecule as a potential diagnostic marker and a possible therapeutic target against liver fibrosis."	31281502	"SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker"	https://pubmed.ncbi.nlm.nih.gov/31281502/	2019
liver	liver_cirrhosis	mus_musculus	Mical2	ENSMUSG00000038244	Ensembl	lncrna	down-regulation	P66SHC	MICAL2; MIR-230-3P; P66SHC	qRT-PCR;  dual-lucimmunofluorescenceerase reporter assay etc.	no	"Our study reveals that p66shc is critical for liver fibrosis and that mical2, journal pre-proof journal pre-proof 4 mir-203a-3p and p66shc compose a novel regulatory pathway in liver fibrosis."	32659284	LncRNA Mical2/miR-203a-3p sponge participates in epithelial-mesenchymal transition by targeting p66Shc in liver fibrosis	https://pubmed.ncbi.nlm.nih.gov/32659284/	2020
liver	liver_cirrhosis	mus_musculus	Pvt1	ENSMUSG00000097039	Ensembl	lncrna	patched2 demethylation	NA	HEDGEHOG SIGNALING PATHWAY	qRT-PCR;  dual-lucimmunofluorescenceerase reporter assay etc.	no	"Pvt1 epigenetically down-regulates ptch1 expression via competitively binding mir-152, contributing to emt process in liver fibrosis."	27588491	Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152	https://pubmed.ncbi.nlm.nih.gov/27588491/	2016
liver	liver_cirrhosis	mus_musculus	Meg3	ENSMUSG00000021268	Ensembl	lncrna	down-regulation	NA	NA	qRT-PCR;  etc.	no	"Serum level of lncrna-meg3 is lowly expressed in chb patients, which is negatively correlated to the liver fibrotic degree. Lncrna-meg3 may serve as a diagnostic biomarker for chb."	31173310	Diagnostic value of LncRNA-MEG3 as a serum biomarker in patients with hepatitis B complicated with liver fibrosis	https://pubmed.ncbi.nlm.nih.gov/31173310/	2019
liver	liver_cirrhosis	mus_musculus	Mecp2	ENSMUSG00000031393	Ensembl	lncrna	phosphorylation	NA	NA	sirna transfection; hyaluronic acid quantimmunofluorescenceication	yes	Strategies to inhibit mecp2 phosphorylation at s80 might be developed for treatment of liver fibrosis.	31352003	Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells	https://pubmed.ncbi.nlm.nih.gov/31352003/	2019
liver	liver_cirrhosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	NA	NA	q-PCR;  dual-lucimmunofluorescenceerase reporter assay etc.	no	The activation of hepatic h19rna promoted cholestatic liver fibrosis in mice through the zeb1;Epcam signaling pathway.	28407375	H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM	https://pubmed.ncbi.nlm.nih.gov/28407375/	2017
liver	liver_cirrhosis	mus_musculus	Trp53cor1	100504267	Gene	lncrna	dysregulation	LINCRNA-P21	TGF-BETA SIGNALING PATHWAY	flow cytometry; H&E staining;  etc.	no	The pleiotropic roles of hepatocyte lincrna-p21 suggest that it may represent an unknown paradigm in liver fibrosis and serve as a potential target for therapy.	28592847	TGF-beta-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice	https://pubmed.ncbi.nlm.nih.gov/28592847/	2017
liver	liver_cirrhosis	mus_musculus	Meg3	ENSMUSG00000021268	Ensembl	lncrna	hypermethylation	MEG3	NA	qRT-PCR;  immunofluorescence etc.	yes	These findings suggested that meg3 may play an important role in stellate cell activation and liver fibrosis progression and act as a novel potential therapeutic target for liver fibrosis.	25201080	Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis	https://pubmed.ncbi.nlm.nih.gov/25201080/	2014
liver	liver_cirrhosis	mus_musculus	HULC	728655	Gene	lncrna	up-regulation	NA	NA	qRT-PCR;  etc.	no	"We confirmed the effects of hulc on tregs differentiation in hbv-related liver cirrhosis. In addition, it was proved that hulc regulates the function of tregs through down-regulated the level of p18 directly."	25952928	LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis	https://pubmed.ncbi.nlm.nih.gov/25952928/	2015
liver	liver_cirrhosis	mus_musculus	Gpr137b-ps	ENSMUSG00000097715	Ensembl	lncrna	up-regulation	LNCRNA GPR137B-PS AND CXCL14	NA	NA	yes	We demonstrated a lncrna gpr137b-ps;Mir-200a-3p;Cxcl14 axis that modulates hsc activation and might exert an effect on the pathogenesis of liver fibrosis.	33069761	A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation	https://pubmed.ncbi.nlm.nih.gov/33069761/	2021
liver	liver_cirrhosis	mus_musculus	Hottip	ENSMUSG00000055408	Ensembl	lncrna	up-regulation	SRF	NA	q-PCR;  dual-lucimmunofluorescenceerase reporter assay etc.	no	We provide a novel hottip-mir-150-srf signalling cascade in liver fibrosis.	30548190	Long noncoding RNA HOTTIP mediates SRF expression through sponging miR-150 in hepatic stellate cells	https://pubmed.ncbi.nlm.nih.gov/30548190/	2019
liver	liver_cirrhosis	mus_musculus	Xist	ENSMUSG00000086503	Ensembl	lncrna	up-regulation	NA	NA	enzyme-linked immunosorbent assay; qRT-PCR;  etc.	no	Xist enhances ethanol-induced hscs autophagy and activation via mir-29b;Hmgb1 axis.	31418997	Long noncoding RNA XIST enhances ethanol-induced hepatic stellate cells autophagy and activation via miR-29b/HMGB1 axis	https://pubmed.ncbi.nlm.nih.gov/31418997/	2019
lung	idiopathic_pulmonary_fibrosis	mus_musculus	Mir17hg	ENSMUSG00000089726	Gene	lncrna	dysregulation	NA	NA	qRT-PCR; Examination of DNA methylation patterns; Dual-luciferase reporter assay etc.	no	"Compared with control samples, miR-17~92 expression was reduced in lung biopsies and lung fibroblasts from patients with IPF, whereas DNMT-1 expression and methylation of the miR-17~92 promoter was increased. Several miRNAs from the miR-17~92 cluster targeted DNMT-1 expression resulting in a negative feedback loop. Similarly, miR-17~92 expression was reduced in the lungs of bleomycin-treated mice. Treatment with 5'-aza-2'-deoxycytidine in a murine bleomycin-induced pulmonary fibrosis model reduced fibrotic gene and DNMT-1 expression, enhanced miR-17~92 cluster expression, and attenuated pulmonary fibrosis."	23306545	Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis	https://www.atsjournals.org/doi/full/10.1164/rccm.201205-0888OC	2013
lung	idiopathic_pulmonary_fibrosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	Col1a1	NA	qRT-PCR;  Dual-luciferase reporter assay etc.	no	"H19 play a promotive role in bleomycin-induced epithelial-mesenchymal transition of alveolar epithelial cell through miR-29b regulation. H19 expression was positively correlated with COL1A1 and Acta2 expression; H19 knockdown inhibited COL1A1 and Acta2 expression. Moreover, H19 interacted with miR-29b through directly binding to the 3'UTR; MiR-29b inhibited COL1A1 expression by directly binding to the 3'UTR. In conclusion, we revealed the promotive effect of H19 on BLM-induced IPF, and demonstrated the mechanism by which H19/miR-29b interaction exerts its effect on regulating pulmonary fibrosis."	27613097	The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis	https://linkinghub.elsevier.com/retrieve/pii/S0006291X16314772	2016
lung	pulmonary_hypertension	mus_musculus	Mir17hg	ENSMUSG00000089726	Gene	lncrna	down-regulation	Pdlim5?	NA	Isolation of Mouse PASMC; Lentivirus-based miR-17?92 Overexpression in HPASMC; PDLIM5 3'-Untranslated Region Luciferase Reporter Assay	no	"Human PASMC (HPASMC) from patients with PAH expressed decreased levels of the miR-17 92 cluster, TGF-B, and SMC markers.  Knockdown of Smad3 but not Smad2 prevented miR-17 92-induced expression of SMC markers. SMC-specific knockout of miR-17 92 attenuated hypoxia-induced pulmonary hypertension (PH) in mice, whereas reconstitution of miR-17 92 restored hypoxia-induced PH in these mice. PDLIM5 is a direct target of miR-17/20a, and hypertensive HPASMC and mouse PASMC expressed elevated PDLIM5 levels. Suppression of PDLIM5 increased expression of SMC markers and enhanced TGF-B/Smad2/3 activity in vitro and enhanced hypoxia-induced PH in vivo, whereas overexpression of PDLIM5 attenuated hypoxia-induced PH."	25647182	Loss of MicroRNA-17 92 in Smooth Muscle Cells Attenuates Experimental Pulmonary Hypertension via Induction of PDZ and LIM Domain 5	https://www.atsjournals.org/doi/10.1164/rccm.201405-0941OC	2015
lung	pulmonary_fibrosis	mus_musculus	NONMMUT021928.2	URS00009B9A54_10090	RNAcentral	lncrna	up-regulation	miR-18a	NA	 qRT-PCR; Immunohistochemistry etc.	no	"In the present study, we identified that lncRNA NONMMUT021928, designated as pulmonary fibrosis-associated lncRNA (PFAL), was up-regulated in the lungs of mice with experimental lung fibrosis, and in TGF-beta1-induced fibrotic lung fibroblasts. Further study showed that overexpression of PFAL promoted cell proliferation, migration, and fibroblast-myofibroblast transition. Overexpression further resulted in extracellular matrix deposition and fibrogenesis in lung fibroblasts through regulation of microRNA-18a (miR-18a). Importantly, knockdown of PFAL alleviated lung fibrosis both in vitro and in vivo. Mechanistically, our study showed that PFAL promoted lung-fibroblast activation and fibrogenesis by acting as a competing endogenous RNA for miR-18a: forced expression of PFAL inhibited the expression and activity of miR-18a, whereas silencing of PFAL had the opposite effect. Furthermore, we found that miR-18a was decreased during lung fibrosis in vitro and in vivo, as well as in patients with IPF. Moreover, knockdown of miR-18a led to fibrogenesis in lung fibroblasts, whereas enhanced expression of miR-18a attenuated TGF-beta1-induced lung fibrosis by directly targeting the regulation of connecting tissue growth factor."	29683732	lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a	https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.201800055R	2018
lung	silicosis	mus_musculus	Chrf	105463121	Gene	lncrna	up-regulation	Myd88; Smad3	NA	qRT-PCR;  Dual-luciferase reporter assay etc.	no	"Levels were reduced in both macrophages that were exposed to silica and fibroblasts that were exposed to TGF-B1. MiR-489 inhibited silica-induced pulmonary fibrosis primarily by repressing its target genes MyD88 and Smad3. Moreover, the up-regulated lncRNA cardiac hypertrophy-related factor (CHRF) reversed the inhibitory effect of miR-489 on MyD88 and Smad3 and then triggered the inflammation and fibrotic signaling pathways."	27506999	MiR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF	https://www.nature.com/articles/srep30921	2016
lung	respiratory_distress_syndrome_acute	mus_musculus	Trp53cor1	100504267	Gene	lncrna	up-regulation	NA	NA	BAL; qRT-PCR;  etc.	no	LincRNA-p21 expression was time-dependently increased and Thy-1 expression was time-dependently reduced in a mouse model of ARDS and in LPS-treated lung fibroblasts. LincRNA-p21 overexpression dramatically inhibited acetylation of H3 and H4 at the Thy-1 promoter and Thy-1 expression levels in HLF1 cells.LincRNA-p21 interference rescued LPS-induced increase of lung and BAL collagen contents. LincRNA-p21 could lead to pulmonary fibrosis in ARDS by inhibition of the expression of Thy-1.	27392907	Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression	https://link.springer.com/article/10.1007%2Fs11010-016-2745-7	2016
lung	respiratory_distress_syndrome_acute	mus_musculus	Trp53cor1	100504267	Gene	lncrna	histone deacetylation	NA	NA	BAL; qRT-PCR;  etc.	no	LincRNA-p21 expression was time-dependently increased and Thy-1 expression was time-dependently reduced in a mouse model of ARDS and in LPS-treated lung fibroblasts. LincRNA-p21 overexpression dramatically inhibited acetylation of H3 and H4 at the Thy-1 promoter and Thy-1 expression levels in HLF1 cells.LincRNA-p21 interference rescued LPS-induced increase of lung and BAL collagen contents. LincRNA-p21 could lead to pulmonary fibrosis in ARDS by inhibition of the expression of Thy-1.	27392907	Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression	https://link.springer.com/article/10.1007%2Fs11010-016-2745-7	2016
lung	idiopathic_pulmonary_fibrosis	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	interact with miRNA	Lsp1; Tnnt3; Mrpl23; Igf2; AC013548.1	NA	qPCR; Knockdown etc.	no	"Moreover, H19 interacted with miR-29b through directly binding to the 3'UTR; miR-29b inhibited COL1A1 expression by directly binding to the 4'UTR."	27613097	The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis	https://linkinghub.elsevier.com/retrieve/pii/S0006291X16314772	2016
lung	idiopathic_pulmonary_fibrosis	mus_musculus	Hoxaas3	ENSMUSG00000085696	Ensembl	lncrna	dysregulation	NA	NA	Immunohistochemistry; Immunofluorescence;  etc.	no	Overexpression of uc.77 or 2700086A05Rik in human lung epithelial cells induced EMT as demonstrated by changes in gene and protein expression of various EMT markers and cell morphology.	26824344	Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929291/	2016
liver	liver_cirrhosis	mus_musculus	Gpr137b-ps	ENSMUSG00000097715	Ensembl	lncrna	up-regulation	LNCRNA GPR137B-PS AND CXCL14	NA	NA	yes	We demonstrated a lncrna gpr137b-ps;Mir-200a-3p;Cxcl14 axis that modulates hsc activation and might exert an effect on the pathogenesis of liver fibrosis.	33069761	A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation	https://pubmed.ncbi.nlm.nih.gov/33069761/	2021
heart	endomyocardial_fibrosis	mus_musculus	Sail	NA	NA	lncrna	down-regulation	NA	TGF-BETA SIGNALING PATHWAY	NA	no	"SAIL inhibited the fibrotic process by directly binding with SAFB via 23 conserved nucleotide sequences, in turn blocked the access of SAFB to RNA pol II (RNA polymerase II) and reduced the transcription of fibrosis-related genes. Intriguingly,the human conserved fragment of SAIL (hSAIL) significantly suppressed the proliferation and collagen production of human cardiac fibroblasts."	33675440	SAIL: a new conserved anti-fibrotic lncRNA in the heart	https://pubmed.ncbi.nlm.nih.gov/33675440/	2021
kidney	kidney_failure_chronic	mus_musculus	Zfas1	ENSMUSG00000074578	Ensembl	lncrna	up-regulation	NA	WNT SIGNALING PATHWAY	dual-luciferase reporter assay	no	LncRNA ZFAS1 from HCM could promote cardiac fibrosis through WNT/beta-catenin signal via exosome pathways.	33640882	Exosome-derived long non-coding RNA ZFAS1 controls cardiac fibrosis in chronic kidney disease	https://pubmed.ncbi.nlm.nih.gov/33640882/	2021
lung	pulmonary_fibrosis	mus_musculus	NONMMUT060091	NA	NA	lncrna	down-regulation	SRSF1	NA	qRT-PCR; Immunofluorescence; Western Blot etc.	no	"A series of molecular assays to assess the role of the novel lncRNA NONMMUT060091, designated as pulmonary fibrosis inhibitor (PFI), which was significantly downregulated in lung fibrosis. Functionally, knockdown of endogenous PFI by smart silencer promoted proliferation, differentiation, and extracellular matrix (ECM) deposition in primary mouse lung fibroblasts (MLFs)."	33981019	The long non-coding RNA PFI protects against pulmonary fibrosis by interacting with splicing regulator SRSF1	https://pubmed.ncbi.nlm.nih.gov/33981019/	2021
heart	myocardial_infarction	mus_musculus	Mhrt	ENSMUSG00000097652	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR;western blot;MTT and EdU assays etc.	no	"Overexpression of MHRT promoted collagen production and CF proliferation, while silencing of MHRT showed the opposite effect."	34334583	LncRNA MHRT Promotes Cardiac Fibrosis via miR-3185 Pathway Following Myocardial Infarction	https://pubmed.ncbi.nlm.nih.gov/34334583/	2021
heart	acute_myocardial_infarction	mus_musculus	Norad	ENSMUSG00000102869	Ensembl	lncrna	up-regulation	NA	NA	RT-qRT-PCR;flow cytometry;western blot	no	NORAD aggravates acute myocardial infarction by promoting fibrosis and apoptosis via the miR-577/COBLL1 axis.	34355838	Long non-coding RNA NORAD aggravates acute myocardial infarction by promoting fibrosis and apoptosis via miR-577/COBLL1 axis	https://pubmed.ncbi.nlm.nih.gov/34355838/	2021
heart	diabetic_cardiomyopathy	mus_musculus	Norad	ENSMUSG00000102869	Ensembl	lncrna	down-regulation	NA	NA	NA	no	NORAD lentivirus shRNA improved cardiac function and fibrosis and reduced inflammatory responses in diabetic cardiomyopathy mice via the ceRNA network of NORAD/miR-125a-3p/Fyn.	34591118	NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn	https://pubmed.ncbi.nlm.nih.gov/34591118/	2021
heart	diabetic_cardiomyopathy	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR;luciferase reporter assay;RNA immunoprecipitation assay	no	GAS5 promotes diabetic cardiomyopathy progression by regulating miR-26a/b-5p.	34091757	Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a/b-5p	https://pubmed.ncbi.nlm.nih.gov/34091757/	2021
heart	heart_failure	mus_musculus	Snhg20	ENSMUSG00000086859	Ensembl	lncrna	down-regulation	miR-335	NA	qRT-PCR; Cell Counting Kit-8 assays;dual-luciferase reporter assay etc.	no	"Downregulation of SNHG20 effectively enhanced cell viability and decreased cell size of HL-1 cells and the expression levels of fibrosis-related proteins (fibronectin, collagen IaI, and alpha-SMA) and apoptosis-related proteins (cleaved caspase-3 and cleaved PARP), which were induced by angiotensin II treatment."	34228494	Inhibition of Long Noncoding RNA SNHG20 Improves Angiotensin II-Induced Cardiac Fibrosis and Hypertrophy by Regulating the MicroRNA 335/ Galectin-3 Axis	https://pubmed.ncbi.nlm.nih.gov/34228494/	2021
heart	myocardial_infarction	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	miR-25-3p	NA	NA	no	"MALAT1 sponged miR-25-3p to upregulate CDC42. miR-25-3p overexpression promoted oxygen-glucose deprivation-treated cell viability, proliferation, and angiogenesis."	34745428	M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis	https://pubmed.ncbi.nlm.nih.gov/34745428/	2021
heart	atrial_fibrosis	mus_musculus	Nron	ENSMUSG00000086484	Ensembl	lncrna	down-regulation	miR-23a	NA	NA	no	NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes.	33246743	LncRNA NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes	https://pubmed.ncbi.nlm.nih.gov/33246743/	2021
heart	myocardial_infarction	mus_musculus	Snhg7	72091	Gene	lncrna	up-regulation	miR-455-3p	NA	qRT-PCR;western blot;flow cytometry etc.	no	"LncRNA SNHG7 depletion exerted protective roles in apoptosis, fibrosis, and inflammation in Ang-II-induced cardiac fibroblasts  by regulating miR-455-3p/PTAFR axis, providing a potential molecular target for myocardial infarction therapy."	33929392	Long Noncoding RNA Small Nuclear RNA Host Gene 7 Knockdown Protects Mouse Cardiac Fibroblasts Against Myocardial Infarction by Regulating miR-455-3p/Platelet-Activating Factor Receptor Axis	https://pubmed.ncbi.nlm.nih.gov/33929392/	2021
heart	myocardial_infarction	mus_musculus	Miat	ENSMUSG00000097767	Ensembl	lncrna	up-regulation	NA	NA	qRT-PCR;western blot	no	"Ablation of Miat attenuates pathological hypertrophy and heart failure, in part, by enhancing cardiomyocyte contractility."	34335976	Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure	https://pubmed.ncbi.nlm.nih.gov/34335976/	2021
kidney	renal_fibrosis	mus_musculus	Gas5	ENSMUSG00000053332	Ensembl	lncrna	down-regulation	NA	NA	NA	no	"Long noncoding RNA growth arrest-specific 5 (GAS5), acting in a renoprotective role via the Smad3/miRNA-142-5p axis, that modulates extracellular matrix formation and cell apoptosis."	34486400	LncRNA GAS5 protects against TGF-beta-induced renal fibrosis via the Smad3/miRNA-142-5p axis	https://pubmed.ncbi.nlm.nih.gov/34486400/	2021
kidney	diabetic_nephropathy	mus_musculus	Isg20	ENSMUSG00000039236	Ensembl	lncrna	up-regulation	NA	NA	RT-qRT-PCR;western blot;luciferase reporter assay etc.	no	Lnc-ISG20 promotes the renal fibrosis process in diabetic nephropathy by activating AKT through the miR-486-5p/NFAT5 axis.	33939247	LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5	https://pubmed.ncbi.nlm.nih.gov/33939247/	2021
kidney	renal_fibrosis	mus_musculus	Xist	ENSMUSG00000086503	Ensembl	lncrna	up-regulation	miR-19b	NA	qRT-PCR;western blot;histology	no	Knockdown of XIST inhibited apoptosis and inflammation of renal fibrosis via miR-19b-mediated downregulation of SOX6.	34461493	Knockdown of lncRNA XIST inhibited apoptosis and inflammation in renal fibrosis via microRNA-19b-mediated downregulation of SOX6	https://pubmed.ncbi.nlm.nih.gov/34461493/	2021
kidney	diabetic_nephropathy	mus_musculus	Rmrp	ENSMUSG00000088088	Ensembl	lncrna	up-regulation	NA	NA	NA	no	Sp1 induced lncRNA Rmrp could drive the expression of JunD via sponging miR-1a-3p in diabetic nephropathy progression.	34512545	Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway	https://pubmed.ncbi.nlm.nih.gov/34512545/	2021
kidney	diabetic_nephropathy	mus_musculus	Sox2ot	ENSMUSG00000105265	Ensembl	lncrna	down-regulation	NA	PI3K-AKT SIGNALING PATHWAY	immunohistochemistry;immunofluorescence;western blot etc.	no	LncRNA SOX2OT alleviates the pathogenesis of diabetic nephropathy via regulating Akt/mTOR-mediated autophagy.	34238205	LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy	https://pubmed.ncbi.nlm.nih.gov/34238205/	2021
kidney	chronic_kidney_disease	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	NA	WNT SIGNALING PATHWAY	qRT-PCR;western blot;dual-luciferase reporter etc.	no	LncRNA-H19 overexpression significantly upregulates Wnt1 and beta-catenin expression in kidney tissues and fibroblasts of mice.	34818249	The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/beta-Catenin Signaling	https://pubmed.ncbi.nlm.nih.gov/34818249/	2022
kidney	acute_kidney_injury	mus_musculus	H19	ENSMUSG00000000031	Ensembl	lncrna	up-regulation	NA	WNT SIGNALING PATHWAY	qRT-PCR;western blot;dual-luciferase reporter etc.	no	LncRNA-H19 overexpression significantly upregulates Wnt1 and beta-catenin expression in kidney tissues and fibroblasts of mice.	34818249	The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/beta-Catenin Signaling	https://pubmed.ncbi.nlm.nih.gov/34818249/	2022
kidney	diabetic_nephropathy	mus_musculus	Malat1	ENSMUSG00000092341	Ensembl	lncrna	up-regulation	NA	NA	the luciferase reporter gene;pull-down assays	no	MALAT1 overexpression may enhance renal fibrosis in diabetic rats and cell damage in high glucose-induced HK-2 cells via the miR-2355-3p/IL6ST axis.	33995063	lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis	https://pubmed.ncbi.nlm.nih.gov/33995063/	2021
kidney	diabetic_nephropathy	mus_musculus	Dlx6os1	ENSMUSG00000090063	Ensembl	lncrna	up-regulation	SOX6	NA	ELISA;RT-qRT-PCR;western blot etc.	no	LncRNA Dlx6os1 accelerates the progression of diabetic nephropathy by epigenetically repressing SOX6 via recruiting EZH2.	35038705	LncRNA Dlx6os1 Accelerates Diabetic Nephropathy Progression by Epigenetically Repressing SOX6 via Recruiting EZH2	https://pubmed.ncbi.nlm.nih.gov/35038705/	2022
kidney	diabetic_nephropathy	mus_musculus	ANRIL	ENSMUSG00000086035	Ensembl	lncrna	down-regulation	NA	NA	NA	no	"Lnc-ANRIL knock-down suppresses mouse mesangial cell proliferation, fibrosis, inflammation, Wnt/beta-catenin and MEK/ERK pathways in diabetic nephropathy."	32726814	"Knock-Down of Long Non-Coding RNA ANRIL Suppresses Mouse Mesangial Cell Proliferation, Fibrosis, Inflammation via Regulating Wnt/beta-Catenin and MEK/ERK Pathways in Diabetic Nephropathy"	https://pubmed.ncbi.nlm.nih.gov/32726814/	2022
